Model Number 3CX*FX15RW30C |
Device Problem
Infusion or Flow Problem (2964)
|
Patient Problem
Hemorrhage/Bleeding (1888)
|
Event Date 12/15/2023 |
Event Type
Injury
|
Manufacturer Narrative
|
Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code 11.
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, there was a defect in the oxygenator causing excessive flow resistance.As per the lead perfusionist, he experience the clinical presentations of an oxygenator failure.Upon initiating bypass, line pressure, flow rate, and rpm's, they were within normal range.After roughly 3-4 minutes he noticed a consistent decrease in arterial line pressure and flow rate which required an increase in rpm's to maintain normal flows.At this point, he confirmed there were no open shunts within the circuit.Additionally, he felt that the oxygenator inlet line was highly pressurized.By the time they made the decision to change the oxygenator, the rpm's were nearly maxed out around 3500-3700 with a subsequent flow rate of 2.6 lpm.The act was in therapeutic range, leading them to believe that there was a defect in the oxygenator fibers causing excessive flow resistance.There was a delay, as the changeout lasted approximately 3 minutes while the patient temperature was 30 degrees celsius.*no consequence or health impact to patient.*there was a blood loss for approximately 250 ml
*procedure was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on january 12, 2024.Upon further investigation of the reported event, the following information is new and/or changed: d4: (additional device information - added exp date).G3: (date received by manufacturer).G6: (indication that this is a follow-up report).H2: (follow-up due to additional information and device evaluation).H3: (device evaluated by manufacturer).H4: (device manufacture date).H6: (identification of evaluation codes 10, 3331, 213, 67).The affected sample was visually inspected upon receipt, no breakage or external anomaly leading to increasing pressure was observed.After it was rinsed and dried, the unit was tested for pressure drop with bovine blood.It was confirmed that a maximum blood flow rate of 5 l/min could be obtained, and the pressure drop was able to meet the factory's specifications with no obstruction found.Saline solution was flowed in the blood channel.As a result, no formation of blood clot was confirmed.As a cause of the occurrence, it was likely that the blood-derived obstruction occurred for some reason.However, with no anomalies found in the actual sample, a possible root cause could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|
|